Literature DB >> 18508606

Host CD147 blockade by small interfering RNAs suppresses growth of human colon cancer xenografts.

Dietmar Abraham1, Karin Zins, Mouldy Sioud, Trevor Lucas, Seyedhossein Aharinejad.   

Abstract

Tumor cells can stimulate matrix metalloproteinase (MMP) production by stromal cells through cell-cell interactions mediated by cell adhesion molecules such as extracellular matrix metalloproteinase inducer (human CD147/EMMPRIN, mouse CD147/Basigin). This study sought to characterize whether specific tumor-stromal cell interactions mediated by CD147 promote colon cancer growth by utilizing small interfering (si)RNAs directed against human CD147/EMMPRIN or mouse CD147/Basigin in co-cultures of cancer cells with macrophages and fibroblasts and established human SW620 colon cancer xenograft models in immune deficient mice. We show that blockade of host (mouse) CD147/Basigin expression, but not cancer cell-derived CD147/EMMPRIN, suppresses tumor growth in human colon cancer xenografts. Experiments in vitro indicated that colon cancer cell-stromal cell interactions mediated by CD147 lead to increased MMP-2 expression in fibroblasts but not macrophages. Furthermore, expression of host VEGF-A in both fibroblasts and macrophages is independent of CD147 in vitro and in vivo. Interestingly, inhibition of cancer cell-derived EMMPRIN leads to increased MMP-9 levels in vivo. Our findings provide new insights into CD147-mediated tumor-host interactions mediating colon cancer growth.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18508606     DOI: 10.2741/3100

Source DB:  PubMed          Journal:  Front Biosci        ISSN: 1093-4715


  9 in total

1.  Up-regulated EMMPRIN/CD147 protein expression might play a role in colorectal carcinogenesis and its subsequent progression without an alteration of its glycosylation and mRNA level.

Authors:  Hua-chuan Zheng; Wei Wang; Xiao-yan Xu; Pu Xia; Miao Yu; Toshiro Sugiyama; Yasuo Takano
Journal:  J Cancer Res Clin Oncol       Date:  2010-06-01       Impact factor: 4.553

2.  Overexpressed BSG related to the progression of lung adenocarcinoma with high-throughput data-mining, immunohistochemistry, in vitro validation and in silico investigation.

Authors:  Wen-Ting Huang; Xia Yang; Rong-Quan He; Jie Ma; Xiao-Hua Hu; Wei-Jia Mo; Gang Chen
Journal:  Am J Transl Res       Date:  2019-08-15       Impact factor: 4.060

3.  Inhibition of stromal PlGF suppresses the growth of prostate cancer xenografts.

Authors:  Karin Zins; Anita Thomas; Trevor Lucas; Mouldy Sioud; Seyedhossein Aharinejad; Dietmar Abraham
Journal:  Int J Mol Sci       Date:  2013-09-03       Impact factor: 5.923

Review 4.  The biological function and clinical utilization of CD147 in human diseases: a review of the current scientific literature.

Authors:  Lijuan Xiong; Carl K Edwards; Lijun Zhou
Journal:  Int J Mol Sci       Date:  2014-09-29       Impact factor: 5.923

5.  Combination of VP3 and CD147-knockdown enhance apoptosis and tumor growth delay index in colorectal tumor allograft.

Authors:  Ruzila Ismail; Zeenathul Nazariah Allaudin; Rasedee Abdullah; Mohd-Azmi Mohd Lila; Nik-Mohd-Afizan Nik Abd Rahman; Sheikh-Omar Abdul Rahman
Journal:  BMC Cancer       Date:  2016-07-13       Impact factor: 4.430

6.  New insights into germ cell migration and survival/apoptosis in spermatogenesis: Lessons from CD147.

Authors:  Hao Chen; Kin Lam Fok; Xiaohua Jiang; Hsiao Chang Chan
Journal:  Spermatogenesis       Date:  2012-10-01

7.  The role of EMMPRIN expression in ovarian epithelial carcinomas.

Authors:  Yang Zhao; Shuo Chen; Wen-feng Gou; Zhe-feng Niu; Shuang Zhao; Li-jun Xiao; Yasuo Takano; Hua-chuan Zheng
Journal:  Cell Cycle       Date:  2013-08-08       Impact factor: 4.534

8.  EMMPRIN regulates tumor growth and metastasis by recruiting bone marrow-derived cells through paracrine signaling of SDF-1 and VEGF.

Authors:  Yanke Chen; Xingchun Gou; Derek Kai Kong; Xiaofei Wang; Jianhui Wang; Zeming Chen; Chen Huang; Jiangbing Zhou
Journal:  Oncotarget       Date:  2015-10-20

Review 9.  SARS-CoV-2: Pathogenesis, and Advancements in Diagnostics and Treatment.

Authors:  Khalil Khalaf; Natalia Papp; Jadzia Tin-Tsen Chou; Doris Hana; Andrzej Mackiewicz; Mariusz Kaczmarek
Journal:  Front Immunol       Date:  2020-10-06       Impact factor: 7.561

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.